AIIMS Delhi Introduces India’s First Portable MRI System for Bedside Brain Imaging

IMT News Desk
IMT News Desk
· 1 min read
AIIMS Delhi launches India’s first portable MRI system for bedside brain imaging

The All India Institute of Medical Sciences (AIIMS) in New Delhi has achieved a significant medical milestone by introducing India’s first portable bedside Magnetic Resonance Imaging (MRI) system.

This groundbreaking ultra-low-field device is designed to be wheeled directly to a patient’s bedside, allowing for rapid brain imaging of critically ill individuals in intensive care units (ICUs), emergency settings and neurosurgical wards. By bringing the scanner to the patient, the facility eliminates the need for potentially risky transfers to conventional, stationary MRI suites, which is particularly beneficial for patients who are unstable or require mechanical ventilation.

Currently in use at the Centre for Neurological Conditions under the leadership of Dr. Shailesh Gaikwad, the system is already enhancing clinical workflows. Clinicians anticipate that this point-of-care technology will lead to faster decision-making in emergencies, such as stroke management, head trauma assessment, and post-operative monitoring.

By streamlining diagnostic procedures and reducing delays, the portable MRI system is expected to improve outcomes for paediatric and adult patients alike, while also strengthening neurodiagnostic research across the country. This implementation, supported by Radiosurgery Global, marks a major step in making advanced neuroimaging more accessible and safer within critical care environments.

Read Next

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care
News
July 17, 2026

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care

Menthra, an AI-powered emotional wellbeing platform, today announced the launch of Menthra Care in India, expanding its platform to connect users with verified therapists, coaches, licensed clinical professionals and care organisations when they need support beyond an AI companion. The launch follows Menthra’s India debut in June, which saw tens of thousands of users join […]
Article by: IMT News Desk
IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care
News
July 17, 2026

IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care

Against a backdrop of geopolitical uncertainty, supply chain disruptions and rapid advances in artificial intelligence (AI) and precision medicine, FutureHealth.Now provided a platform for industry leaders to explore how innovation, technology and new models of care can help tackle rising healthcare costs, workforce pressures and growing demand for services across the region. At his opening […]
Article by: IMT News Desk
Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill
News
July 16, 2026

Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill

Novo Nordisk has secured European Commission approval for its once-daily Wegovy pill, giving the Danish drugmaker a major boost in the fast-growing obesity-treatment market. The approval makes it the first oral GLP-1 weight-loss treatment cleared in the European Union for adults with obesity or overweight who also have at least one weight-related health condition. The […]
Article by: IMT News Desk
Sun Pharma Wins South Africa Approval to Launch Generic Ozempic
News
July 16, 2026

Sun Pharma Wins South Africa Approval to Launch Generic Ozempic

India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, expanding its presence in the fast-growing GLP-1 market. The South African Health Products Regulatory Authority’s clearance allows Sun Pharma to market the injectable treatment for […]
Article by: IMT News Desk